Le Lézard
Classified in: Environment, Health
Subjects: ENI, ENP, ANW, CFG

Health Canada launches consultation on use of imidacloprid pesticide


Some uses of this neonicotinoid are proposed for phase out to protect bees and other pollinators

OTTAWA, May 31, 2018 /CNW/ - Canadians care about how the use of pesticides impacts the environment. The Government of Canada relies on scientific evidence to evaluate pesticides so that they are used safely and do not threaten human health or the environment. With that in mind, the Government of Canada is consulting Canadians on its latest proposal to protect bees and other pollinators from exposure to imidacloprid, a neonicotinoid pesticide.

Health Canada's scientific assessment of imidacloprid looked at the effects of this pesticide on pollinators such as honey bees, bumble bees and solitary bees. The assessment found that there are some uses of imidacloprid that may pose a risk to bees. The Department is therefore proposing significant restrictions on the use of imidacloprid products to protect bees and other pollinators. These proposed restrictions include the cancellation of some uses, restrictions on the timing of use, and new product labels.

Consultations on this proposed decision will be open to the public for 90 days. Comments received during this consultation will be considered along with input from previous consultations, including separate restrictions that were proposed in 2016 to protect aquatic insects. We expect to publish a final decision on the overall use of imidacloprid in Canada in December 2018.

Health Canada's primary objective in regulating pesticides is to protect the health of Canadians and the environment. All pesticides must undergo a rigorous science-based review before being approved for sale in Canada.

Quick Facts

Related Products
Backgrounder: Proposed Re-evaluation Decision: Imidacloprid ? Pollinator (Bee) Assessment

Associated Links
PRVD2018-12: Proposed Re-evaluation Decision on Imidacloprid (Pollinator Assessment) 
PRVD2016-20: Proposed Re-evaluation Decision on Imidacloprid 
December 2017 Update on Neonicotinoid Pesticides
PRVD2017-23: Proposed Re-evaluation Decision on Clothianidin and Its Associated End-use Products: Pollinator Re-evaluation 
PRVD2017-24: Proposed Re-evaluation Decision on Thiamethoxam and Its Associated End-use Products: Pollinator Re-evaluation 
Update on Bee Incident Reports 2012-2016

 

SOURCE Health Canada


These press releases may also interest you

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...



News published on and distributed by: